The use of a cationic liposome formulation (DOTAP) mixed with a recombinant tumor-associated antigen to induce immune responses and protective immunity in mice

The cationic liposome DOTAP is a well-known transfection reagent. It has been manufactured and approved for clinical use, is readily available, and can be easily used as an adjuvant. These characteristics prompted us to investigate the effectiveness of DOTAP as an adjuvant to induce immune responses...

Full description

Saved in:
Bibliographic Details
Published inJournal of immunotherapy (1997) Vol. 21; no. 3; p. 159
Main Authors Bei, R, Guptill, V, Masuelli, L, Kashmiri, S V, Muraro, R, Frati, L, Schlom, J, Kantor, J
Format Journal Article
LanguageEnglish
Published United States 01.05.1998
Subjects
Online AccessGet more information

Cover

Loading…